홈 > 시장보고서 > 의료기기 > 체외진단

시장보고서

상품코드

1389612

세계 감염증 진단 시장 규모 및 예측 - 지역별 점유율, 동향, 성장 기회 분석 : 제품별, 기술별, 용도별, 유형별, 검사 유형별, 최종 사용자별

Infectious Disease Diagnostics Market Size and Forecasts, Global and Regional Share, Trends, and Growth Opportunity Analysis By Product, Technology , Application Type, Testing Type, End User, and Geography

발행일: 2023년 11월 | 리서치사:

The Insight Partners | 페이지 정보: 영문 280 Pages | 배송안내 : 즉시배송

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

감염증 진단 시장은 2022년 383억 6,600만 달러에서 2030년에는 599억 5,400만 달러로 성장할 것으로 예측되고 있으며, 2022-2030년간 CAGR은 5.7%로 예측되고 있습니다. 세계 감염증 이환율 증가와 가축전염병에 있어서의 진단약의 용도 확대가 감염증 진단 시장 규모를 밀어 올리고 있습니다. 그러나 불충분한 상환 시나리오는 감염증 진단 시장의 성장을 저해하고 있습니다.

감염증 이환율의 상승이 감염증 진단 시장의 성장을 견인

곰팡이, 바이러스, 기생충, 박테리아, 독성 제품 등은 감염을 일으킬 수 있는 감염 인자 중 하나입니다. 공중 보건은 감염에 의해 악영향을 받으며 이환율, 사망률, 경제적 부담을 유발합니다. 감염 증가는 효과적인 질병 관리, 치료 및 예방의 기초가 되는 정확하고 시기 적절한 진단의 필요성을 증가시키고 있습니다. C형 간염, HIV, 결핵, 인유두종 바이러스, 성감염증(STI) 등 여러 감염이나 질환, 감염증 아웃브레이크의 진단과 모니터링은 분자진단기술, 실험실 기반의 분석, 포인트 오브 케어 검사를 이용 할 수 있습니다. 미국 질병 예방 관리 센터(CDC)에 따르면, 아프리카 국가에서는 매년 1,020만 명이 감염과 기생충증 치료를 위해 진료소를 방문하고 있습니다. 2021년 National Library of Medicine(NLM)에 게재된 논문에 따르면 감염은 질병 부담이 크고 건강 관리 자원이 제한되어 있기 때문에 대부분의 아프리카 국가에서 큰 우려가 되고 있습니다. 나이지리아에서는 200개 이상의 병원체가 발열을 일으킬 수 있으며 건강 관리 시설을 방문하는 가장 일반적인 이유 중 하나입니다. 세계보건기구(WHO)에 따르면 세계 5,800만 명 이상이 C형 만성 간염을 앓고 있으며, 매년 150만 명이 새로 감염된 것으로 진단되고 있습니다. HIV는 세계에서 공중 보건에 큰 문제가되고 있습니다. UN 연합 에이즈 계획(UNAIDS)에 따르면 2020년에는 3,770만 명이 HIV에 감염되었습니다. 그 중 3,600만명이 성인으로, 0-14세의 어린이가 약 170만명입니다. 또한 2020년에 세계에서 새롭게 보고된 HIV 감염자는 -150만명입니다.

WHO에 따르면 결핵은 세계 사망의 13위이며 COVID-19에 이어 사망으로 이어지는 감염의 2위입니다. WHO에 따르면 2020년에는 결핵으로 인해 150만 명이 사망한다고 합니다. WHO는 세계 1,000만 명이 결핵을 앓고 있다고 생각하며, 2020년에는 결핵의 이환율이 높은 30개국이 결핵 신규 환자의 86%를 차지할 것으로 예측했습니다. 인도를 필두로 중국, 필리핀, 인도네시아, 나이지리아, 파키스탄, 방글라데시, 남아프리카의 8개국이 결핵 환자 전체의 3분의 2를 차지하고 있습니다. 이와 같이 감염증의 급증은 미생물 배양, 적혈구 응집 저해 시험, 효소 결합 면역흡착 측정법(ELISA) 등의 감염증 진단 기술의 필요성을 높이고 있습니다.

본 보고서에서는 감염증 진단 시장을 다음과 같이 구분합니다.

전염병 진단 시장을 제품별로 분류하면 키트 및 시약, 장비, 소프트웨어 및 서비스로 나뉩니다. 감염증 진단 시장을 기술별로 분류하면 바이오센서, 면역진단, 분자진단, 임상 생물학 등으로 나눌 수 있습니다. 면역 진단 시장은 또한 효소 결합 면역 흡착 분석, 웨스턴 블롯 분석, 면역 형광 분석으로 구분됩니다. 분자 기반 진단 기술 시장은 또한 중합 효소 연쇄반응, in situ 하이브리드 화 등온 핵산 증폭 기술, 차세대 시퀀싱, DNA 마이크로어레이 등으로 구분됩니다. 감염증 진단 시장은 용도별로 포인트 오브 케어 검사와 실험실 검사로 이분됩니다. 감염증 진단 시장은 검사 유형별로 인간 검사와 동물 검사로 구분됩니다. 인간 검사 시장은 또한 HIV, 간염, HAI, HPV, 결핵, 독감 등으로 구분됩니다. 최종사용자별 감염증 진단 시장은 진단실, 병원 및 진료소, 연구기관, 재택의료현장 등으로 구분됩니다. 지역별로 감염증 진단 시장은 북미(미국, 캐나다, 멕시코), 유럽(영국, 독일, 프랑스, 이탈리아, 스페인, 기타 유럽), 아시아태평양(중국, 일본, 인도, 한국, 호주, 기타 아시아태평양), 중동 및 아프리카(아랍에미리트(UAE), 사우디아라비아, 한국, 호주 및 기타 중동 및 아프리카), 남미(브라질, 아르헨티나 및 기타 중동 및 아프리카)로 구분됩니다.

제품별 인사이트

감염증 진단 시장은 제품별로 키트 및 시약, 장비, 소프트웨어 및 서비스로 구분됩니다. 2022년에는 키트 & 시약 부문이 시장에서 가장 큰 점유율을 차지했습니다. 그러나 소프트웨어 및 서비스 분야 시장은 2022-2030년에 가장 빠른 속도로 성장할 것으로 예상됩니다.

지역별 인사이트

지역별로 보면 감염증 진단 시장은 북미, 유럽, 아시아태평양, 중동, 아프리카, 중남미로 구분됩니다. 북미는 세계의 감염증 진단 시장의 성장에 가장 기여하고 있습니다. 아시아태평양은 2022-2030년 전염병 진단 시장에서 가장 높은 CAGR을 기록할 것으로 예상됩니다. 미국에서의 감염증 진단 시장의 성장은 주로 감염증의 유행 증가, 노인 인구 증가, 주요 기업에 의한 제품 상시 수 증가에 의해 초래됩니다.

Abbott Laboratories, Bruker Corp, Cardinal Health, F. Hoffmann-La Roche Ltd, Trinity Biotech Plc, Danaher Corp, Bio-Rad Laboratories Inc, AccuBioTech Co Ltd, ACON Laboratories, DiaSorin SpA 등이 전염병 진단 시장에서 사업 개발 하는 유력 기업입니다. 이러한 기업들은 세계적으로 확대되는 소비자 수요에 대응하고 전문 포트폴리오의 제품 범위를 확대하기 위해 신제품 출시와 지리적 확대에 주력하고 있습니다. 세계적인 존재로 많은 고객에게 서비스를 제공하고 시장 확대를 촉진하고 있습니다.

전염병 진단 시장에 관한 본 보고서를 작성할 때 참조하는 주요 1차 및 2차 정보로는 세계보건기구(WHO), 미국 인구조사국, The Journal for Infectious Diseases, International Journal of Infectious Diseases, CDC 등이 있습니다.

시장 성장 촉진요인:
- 감염증 이환율의 상승
- 가축전염병에서 진단약 용도 확대
시장 성장 억제요인
- 불충분한 상환 시나리오
시장 기회
- 감염증 진단의 연구 개발과 자금 조달에 대한 주목 고조
향후의 동향
- 제품의 승인 및 출시수 증가
영향 분석

제6장 감염증 진단 시장 - 세계 시장 분석

감염증 진단 시장의 수익(2022-2030년)

제7장 감염증 진단 세계 시장 - 제품별 수익과 예측(-2030년)

개요
감염증 진단 시장의 수익 점유율, 제품별(2022년 및 2030년)
키트 및 시약
기기
소프트웨어 및 서비스

제8장 감염증 진단 세계 시장 - 기술별 수익과 예측(-2030년)

개요
감염증 진단 시장의 수익 점유율, 기술별(2022년 및 2030년)
바이오센서 베이스
면역진단제
분자 기반 진단 기술
임상 생물학
기타

제9장 감염증 진단 세계 시장 - 용도별 수익과 예측(-2030년)

개요
감염증 진단 시장의 수익 점유율(2022년 및 2030년), 용도별
포인트 오브 케어 검사
실험실 검사

제10장 감염증 진단 세계 시장 : 검사 유형별 수익과 예측(-2030년)

개요
감염증 진단 시장의 수익 점유율(2022년 및 2030년), 검사 유형별
인간 검사
동물용 검사

제11장 전염병 진단 세계 시장 - 최종 사용자별 수익과 예측(-2030년)

개요
감염증 진단 시장의 수익 점유율,(2022년 및 2030년), 최종 사용자별
진단 실험실
병원 및 진료소
연구기관
재택 간호
기타

제12장 감염증 진단 시장 분석 : 지역별

개요
북미 감염증 진단 시장 : 제품별(2020-2030년)
북미 감염증 진단 시장 : 기술별(2020-2030년)
- 북미 감염증 진단 시장 : 기술별, 면역 진단약(2020-2030년)
- 북미 감염증 진단 시장 : 기술별, 분자 기반 진단 기술(2020-2030년)
북미 감염증 진단 시장 : 용도별(2020-2030년)
북미 감염증 진단 시장 : 검사 유형별(2020-2030년)
- 북미 : 인체 검사용 감염증 진단 시장 : 검사 유형별(2020-2030년)
북미 감염증 진단 시장 : 최종 사용자별(2020-2030년)
북미 감염증 진단 시장 : 국가별
- 미국
- 캐나다
- 멕시코
개요
유럽 감염증 진단 시장 : 제품별(2020-2030년)
유럽 감염증 진단 시장 : 기술별(2020-2030년)
- 유럽 감염증 진단 시장 : 기술별(2020-2030년)
- 유럽 감염증 진단 시장 : 분자 기반 진단 기술: 기술별(2020-2030년)
유럽 감염증 진단 시장 : 용도별(2020-2030년)
유럽 감염증 진단 시장 : 검사 유형별(2020-2030년)
- 유럽 감염증 진단 시장 : 인간 검사용, 검사 유형별(2020-2030년)
유럽 감염증 진단 시장 : 최종 사용자별(2020-2030년)
유럽 감염증 진단 시장 : 국가별
- 영국
- 독일
- 프랑스
- 이탈리아
- 스페인
- 기타 유럽
개요
아시아태평양 감염증 진단 시장 : 제품별(2020-2030년)
아시아태평양 감염증 진단 시장 : 기술별(2020-2030년)
- 아시아태평양 감염증 진단 시장 : 기술별, 면역 진단약(2020-2030년)
- 아시아태평양 감염증 진단 시장 : 기술별, 분자 기반 진단 기술(2020-2030년)
아시아태평양 감염증 진단 시장 : 용도별(2020-2030년)
아시아태평양 감염증 진단 시장 : 검사 유형별(2020-2030년)
- 아시아태평양 인체 검사용 감염증 진단 시장 : 검사 유형별(2020-2030년)
아시아태평양 감염증 진단 시장 : 최종 사용자별(2020-2030년)
아시아태평양 감염증 진단 시장 : 국가별
- 중국
- 일본
- 인도
- 한국
- 호주
- 기타 아시아태평양
개요
중동 및 아프리카 감염증 진단 시장 : 제품별(2020-2030년)
중동 및 아프리카 감염증 진단 시장 : 기술별(2020-2030년)
- 중동 및 아프리카 감염증 진단 시장 : 기술별, 면역 진단약(2020-2030년)
- 중동 및 아프리카 감염증 진단 시장 : 기술별, 분자 베이스 진단 기술(2020-2030년)
중동 및 아프리카 감염증 진단 시장 : 용도별(2020-2030년)
중동 및 아프리카 감염증 진단 시장 : 검사 유형별(2020-2030년)
- 중동 및 아프리카 인체 검사용 감염증 진단 시장 : 검사 유형별(2020-2030년)
중동 및 아프리카 감염증 진단 시장 : 최종 사용자별(2020-2030년)
- 중동 및 아프리카 감염증 진단 시장 : 국가별
- 사우디아라비아
- 남아프리카
- 아랍에미리트(UAE)
- 기타 중동 및 아프리카
개요
중남미 감염증 진단 시장 : 제품별(2020-2030년)
중남미 감염증 진단 시장 : 기술별(2020-2030년)
- 중남미 감염증 진단 시장 : 기술별, 면역 진단(2020-2030년)
- 중남미 감염증 진단 시장 : 기술별, 분자 베이스 진단 기술(2020-2030년)
중남미 감염증 진단 시장 : 용도별(2020-2030년)
중남미 감염증 진단 시장 : 검사 유형별(2020-2030년)
- 중남미 인체 검사용 감염증 진단 시장 : 검사 유형별(2020-2030년)
중남미 감염증 진단 시장 : 최종 사용자별(2020-2030년)
중남미 감염증 진단 시장 : 국가별
- 브라질

JHS 23.12.15

The infectious disease diagnostics market is expected to grow from US$ 38.366 billion in 2022 to US$ 59.954 billion by 2030; it is anticipated to register a CAGR of 5.7% from 2022 to 2030. The growing incidence of infectious diseases across the world and rising application of diagnostics in veterinary infectious diseases bolster the infectious disease diagnostics market size. However, an inadequate reimbursement scenario hinders the infectious disease diagnostics market growth.

Rising Incidence of Infectious Diseases Drive Infectious Disease Diagnostics Market Growth

Fungi, viruses, parasites, bacteria, and toxic products are among the infectious agents that can cause infectious diseases. Public health is adversely affected by infectious diseases, causing morbidity, mortality, and economic burdens. Rising incidence of infectious diseases propels the requirement for accurate and timely diagnosis to form the basis for effective disease management, treatment, and prevention. Diagnosing and monitoring multiple infections and diseases, including hepatitis C, HIV, tuberculosis, human papillomavirus, and sexually transmitted infections (STIs), and infectious disease outbreaks can be performed using molecular diagnostics techniques, laboratory-based assays, and point-of-care tests. According to the Centers for Disease Control and Prevention (CDC), ~10.2 million people visited physician offices for the treatment of infectious and parasitic diseases in African countries every year. According to an article published in the National Library of Medicine (NLM) in 2021, infectious diseases are a major concern in most African countries due to high disease burden and limited healthcare resources. More than 200 pathogens can cause fever in Nigeria, one of the most common reasons for visiting a healthcare facility. According to the World Health Organization (WHO), ~58 million people across the world suffer from chronic hepatitis C infection, and ~1.5 million new infections are diagnosed every year. HIV is a major public health issue across the world. According to The Joint United Nations Programme on HIV/AIDS (UNAIDS), in 2020, ~ 37.7 million people had HIV. Out of these, ~36 million people were adults, and about 1.7 million were children aged 0-14 years. Also, ~1.5 million new HIV cases were reported globally in 2020.

According to WHO, tuberculosis (TB) is the 13th leading cause of death across the world, and it is the second leading infectious disease that leads to death after COVID-19. According to the WHO, 1.5 million deaths were caused by TB in 2020. In 2020, WHO projected that 10 million people had TB across the world, Furthermore, in 2020, 30 countries with high TB burdens accounted for 86% of new TB cases. Eight countries make up two-thirds of the total cases of TB, with India at the forefront, followed by China, the Philippines, Indonesia, Nigeria, Pakistan, Bangladesh, and South Africa. Thus, the upsurging incidence of infectious diseases bolsters the need for infectious disease diagnostic technologies, such as microbial culture, hemagglutination inhibition tests, and enzyme-linked immunosorbent assays (ELISA).

The report segments the infectious disease diagnostics market as follows:

The infectious disease diagnostics market, by product, is segmented into kits & reagents, instruments, and software & services. The infectious disease diagnostics market, by technology, is segmented into biosensor-based, immunodiagnostics, molecular-based diagnostic, clinical biology, and others. The market for the immunodiagnostics segment is further segmented into enzyme-linked immunosorbent assay, western blotting analysis, and immunofluorescence assay. The market for the molecular-based diagnostic techniques segment is further segmented into polymerase chain reaction, in situ hybridization, isothermal nucleic acid amplification technology, next generation sequencing, DNA microarrays, and others. The infectious disease diagnostics market, by application type, is bifurcated into point-of-care testing and laboratory testing. The infectious disease diagnostics market, by testing type, is bifurcated into human testing and veterinary testing. The market for the human testing segment is further segmented into HIV, Hepatitis, HAIs, HPV, tuberculosis, influenza, and others. The infectious disease diagnostics market, by end user, is segmented into diagnostic laboratories, hospitals and clinics, research institutes, homecare settings, and others. Based on geography, the infectious disease diagnostics market is segmented into North America (the US, Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific), the Middle East & Africa (the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).

Product-Based Insights

The infectious disease diagnostics market, by product, is segmented into kits & reagents, instruments, and software & services. In 2022, the kits & reagents segment held the largest share of the market. However, the market for the software & services segment is expected to grow at the fastest rate during 2022-2030.

Regional-Based Insights

Based on geography, the infectious disease diagnostics market is segmented into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. North America is the largest contributor to the growth of the global infectious disease diagnostics market. Asia Pacific is expected to register the highest CAGR in the infectious disease diagnostics market during 2022-2030. The infectious diseases diagnostics market growth in the US is primarily driven by the increasing prevalence of infectious diseases, rising geriatric population, and growing number of product launches by key players.

Abbott Laboratories, Bruker Corp, Cardinal Health, F. Hoffmann-La Roche Ltd, Trinity Biotech Plc, Danaher Corp, Bio-Rad Laboratories Inc, AccuBioTech Co Ltd, ACON Laboratories, and DiaSorin SpA are among the prominent players operating in the infectious disease diagnostics market. These companies focus on new product launches and geographic expansions to meet the growing consumer demand across the world and increase their product range in specialty portfolios. Their global presence allows them to serve a large base of customers, subsequently facilitating market expansion.

A few of the major primary and secondary sources referred to while preparing the report on the infectious disease diagnostics market are the World Health Organization (WHO), the US Census Bureau, The Journal for Infectious Diseases, International Journal of Infectious Diseases, and CDC, among others.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the infectious disease diagnostics market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the global infectious disease diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth global infectious disease diagnostics market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

1. Introduction 39

1.1 The Insight Partners Research Report Guidance. 39
1.2 Market Segmentation. 40

2. Executive Summary 42

2.1 Key Insights. 42
2.2 Infectious Disease Diagnostics Market, by Geography (US$ Million) 43

3. Research Methodology 44

3.1 Coverage. 45
3.2 Secondary Research. 45
3.3 Primary Research. 45

4. Infectious Disease Diagnostics Market Landscape 47

4.1 Overview. 47
4.2 PEST Analysis. 47
- 4.2.1 Global PEST Analysis. 47

5. Infectious Disease Diagnostics Market - Key Industry Dynamics 48

5.1 Market Drivers: 48
- 5.1.1 Rising Incidence of Infectious Diseases. 48
- 5.1.2 Rising Application of Diagnostics in Veterinary Infectious Disease. 50
5.2 Market Restraints. 50
- 5.2.1 Inadequate Reimbursement Scenario. 50
5.3 Market Opportunities. 51
- 5.3.1 Increasing Focus on R&D and Funding in Infectious Disease Diagnostics. 51
5.4 Future Trends. 52
- 5.4.1 Rising Number of Product Approvals and Launches. 52
5.5 Impact Analysis: 52

6. Infectious Disease Diagnostics Market - Global Market Analysis 54

6.1 Infectious Disease Diagnostics Market Revenue (US$ Mn), 2022 - 2030. 54

7. Global Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 - by Product 56

7.1 Overview. 56
7.2 Infectious Disease Diagnostics Market Revenue Share, by Product, 2022 & 2030 (%) 56
7.3 Kits & Reagents. 57
- 7.3.1 Overview. 57
- 7.3.2 Kits & Reagents: Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million) 57
7.4 Instruments. 58
- 7.4.1 Overview. 58
- 7.4.2 Instruments: Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million) 58
7.5 Software & Services. 59
- 7.5.1 Overview. 59
- 7.5.2 Software & Services: Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million) 59

8. Global Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 - by Technology 60

8.1 Overview. 60
8.2 Infectious Disease Diagnostics Market Revenue Share, by Technology, 2022 & 2030 (%) 60
8.3 Biosensor-based. 61
- 8.3.1 Overview. 61
- 8.3.2 Biosensor-based: Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million) 61
8.4 Immunodiagnostics. 62
- 8.4.1 Overview. 62
- 8.4.2 Immunodiagnostics: Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million) 62
  - 8.4.2.1 Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million) 63
8.5 Molecular-Based Diagnostic Techniques. 64
- 8.5.1 Overview. 64
- 8.5.2 Molecular-Based Diagnostic Techniques: Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million) 64
  - 8.5.2.1 Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million) 64
8.6 Clinical Biology. 66
- 8.6.1 Overview. 66
- 8.6.2 Clinical Biology: Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million) 66
8.7 Others. 67
- 8.7.1 Overview. 67
- 8.7.2 Others: Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million) 67

9. Global Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 - by Application Type 68

9.1 Overview. 68
9.2 Infectious Disease Diagnostics Market Revenue Share, by Application Type, 2022 & 2030 (%) 68
9.3 Point-of-Care Testing. 69
- 9.3.1 Overview. 69
- 9.3.2 Point-of-Care Testing: Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million) 69
9.4 Laboratory Testing. 70
- 9.4.1 Overview. 70
- 9.4.2 Laboratory Testing: Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million) 70

10. Global Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 - by Testing Type 71

10.1 Overview. 71
10.2 Infectious Disease Diagnostics Market Revenue Share, by Testing Type, 2022 & 2030 (%) 71
10.3 Human Testing. 72
- 10.3.1 Overview. 72
- 10.3.2 Human Testing: Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million) 72
  - 10.3.2.1 Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million) 73
10.4 Veterinary Testing. 74
- 10.4.1 Overview. 74
- 10.4.2 Veterinary Testing: Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million) 74

11. Global Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 - by End User 75

11.1 Overview. 75
11.2 Infectious Disease Diagnostics Market Revenue Share, by End User, 2022 & 2030 (%) 75
11.3 Diagnostic Laboratories. 76
- 11.3.1 Overview. 76
- 11.3.2 Diagnostic Laboratories: Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million) 76
11.4 Hospitals and Clinics. 77
- 11.4.1 Overview. 77
- 11.4.2 Hospitals and Clinics: Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million) 77
11.5 Research Institutes. 78
- 11.5.1 Overview. 78
- 11.5.2 Research Institutes: Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million) 78
11.6 Homecare Settings. 80
- 11.6.1 Overview. 80
- 11.6.2 Homecare Settings: Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million) 80
11.7 Others. 81
- 11.7.1 Overview. 81
- 11.7.2 Others: Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million) 81

12. Infectious Disease Diagnostics Market - Geographical Analysis 82

12.1 North America Infectious Disease Diagnostics Market, Revenue and Forecast To 2030. 82
- 12.1.1 Overview. 82
- 12.1.2 North America Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 83
- 12.1.3 North America: Infectious Disease Diagnostics Market, by Product, 2020-2030 (US$ Million) 83
- 12.1.4 North America: Infectious Disease Diagnostics Market, by Technology, 2020-2030 (US$ Million) 84
  - 12.1.4.1 North America: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million) 84
  - 12.1.4.2 North America: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million) 85
- 12.1.5 North America: Infectious Disease Diagnostics Market, by Application Type, 2020-2030 (US$ Million) 85
- 12.1.6 North America: Infectious Disease Diagnostics Market, by Testing Type, 2020-2030 (US$ Million) 86
  - 12.1.6.1 North America: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million) 86
- 12.1.7 North America: Infectious Disease Diagnostics Market, by End User, 2020-2030 (US$ Million) 87
- 12.1.8 North America Infectious Disease Diagnostics Market, by Country. 87
  - 12.1.8.1 US. 88
    - 12.1.8.1.1 Overview
    - 12.1.8.1.2 US Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 88
    - 12.1.8.1.3 US: Infectious Disease Diagnostics Market, by Product, 2020-2030 (US$ Million) 88
    - 12.1.8.1.4 US: Infectious Disease Diagnostics Market, by Technology, 2020-2030 (US$ Million) 90
    - 12.1.8.1.4.1 US: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million) 90
    - 12.1.8.1.4.2 US: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million) 91
    - 12.1.8.1.5 US: Infectious Disease Diagnostics Market, by Application Type, 2020-2030 (US$ Million) 92
    - 12.1.8.1.6 US: Infectious Disease Diagnostics Market, by Testing Type, 2020-2030 (US$ Million) 92
    - 12.1.8.1.6.1 US: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million) 92
    - 12.1.8.1.7 US: Infectious Disease Diagnostics Market, by End User, 2020-2030 (US$ Million) 93
  - 12.1.8.2 Canada. 94
    - 12.1.8.2.1 Overview
    - 12.1.8.2.2 Canada Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 94
    - 12.1.8.2.3 Canada: Infectious Disease Diagnostics Market, by Product, 2020-2030 (US$ Million) 95
    - 12.1.8.2.4 Canada: Infectious Disease Diagnostics Market, by Technology, 2020-2030 (US$ Million) 96
    - 12.1.8.2.4.1 Canada: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million) 96
    - 12.1.8.2.4.2 Canada: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million) 97
    - 12.1.8.2.5 Canada: Infectious Disease Diagnostics Market, by Application Type, 2020-2030 (US$ Million) 97
    - 12.1.8.2.6 Canada: Infectious Disease Diagnostics Market, by Testing Type, 2020-2030 (US$ Million) 98
    - 12.1.8.2.6.1 Canada: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million) 98
    - 12.1.8.2.7 Canada: Infectious Disease Diagnostics Market, by End User, 2020-2030 (US$ Million) 99
  - 12.1.8.3 Mexico. 100
    - 12.1.8.3.1 Overview
    - 12.1.8.3.2 Mexico Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 100
    - 12.1.8.3.3 Mexico: Infectious Disease Diagnostics Market, by Product, 2020-2030 (US$ Million) 101
    - 12.1.8.3.4 Mexico: Infectious Disease Diagnostics Market, by Technology, 2020-2030 (US$ Million) 102
    - 12.1.8.3.4.1 Mexico: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million) 102
    - 12.1.8.3.4.2 Mexico: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million) 103
    - 12.1.8.3.5 Mexico: Infectious Disease Diagnostics Market, by Application Type, 2020-2030 (US$ Million) 103
    - 12.1.8.3.6 Mexico: Infectious Disease Diagnostics Market, by Testing Type, 2020-2030 (US$ Million) 103
    - 12.1.8.3.6.1 Mexico: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million) 104
    - 12.1.8.3.7 Mexico: Infectious Disease Diagnostics Market, by End User, 2020-2030 (US$ Million) 104
12.2 Europe Infectious Disease Diagnostics Market, Revenue and Forecast to 2030. 105
- 12.2.1 Overview. 105
- 12.2.2 Europe Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 106
- 12.2.3 Europe: Infectious Disease Diagnostics Market, by Product, 2020-2030 (US$ Million) 106
- 12.2.4 Europe: Infectious Disease Diagnostics Market, by Technology, 2020-2030 (US$ Million) 107
  - 12.2.4.1 Europe: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million) 107
  - 12.2.4.2 Europe: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million) 108
- 12.2.5 Europe: Infectious Disease Diagnostics Market, by Application Type, 2020-2030 (US$ Million) 108
- 12.2.6 Europe: Infectious Disease Diagnostics Market, by Testing Type, 2020-2030 (US$ Million) 109
  - 12.2.6.1 Europe: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million) 109
- 12.2.7 Europe: Infectious Disease Diagnostics Market, by End User, 2020-2030 (US$ Million) 110
- 12.2.8 Europe Infectious Disease Diagnostics Market, by Country. 110
  - 12.2.8.1 UK
    - 12.2.8.1.1 Overview
    - 12.2.8.1.2 UK Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 111
    - 12.2.8.1.3 UK: Infectious Disease Diagnostics Market, by Product, 2020-2030 (US$ Million) 111
    - 12.2.8.1.4 UK: Infectious Disease Diagnostics Market, by Technology, 2020-2030 (US$ Million) 113
    - 12.2.8.1.4.1 UK: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million) 113
    - 12.2.8.1.4.2 UK: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million) 114
    - 12.2.8.1.5 UK: Infectious Disease Diagnostics Market, by Application Type, 2020-2030 (US$ Million) 114
    - 12.2.8.1.6 UK: Infectious Disease Diagnostics Market, by Testing Type, 2020-2030 (US$ Million) 115
    - 12.2.8.1.6.1 UK: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million) 115
    - 12.2.8.1.7 UK: Infectious Disease Diagnostics Market, by End User, 2020-2030 (US$ Million) 116
  - 12.2.8.2 Germany. 117
    - 12.2.8.2.1 Overview
    - 12.2.8.2.2 Germany Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 117
    - 12.2.8.2.3 Germany: Infectious Disease Diagnostics Market, by Product, 2020-2030 (US$ Million) 118
    - 12.2.8.2.4 Germany: Infectious Disease Diagnostics Market, by Technology, 2020-2030 (US$ Million) 119
    - 12.2.8.2.4.1 Germany: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million) 119
    - 12.2.8.2.4.2 Germany: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million) 120
    - 12.2.8.2.5 Germany: Infectious Disease Diagnostics Market, by Application Type, 2020-2030 (US$ Million) 120
    - 12.2.8.2.6 Germany: Infectious Disease Diagnostics Market, by Testing Type, 2020-2030 (US$ Million) 121
    - 12.2.8.2.6.1 Germany: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million) 121
    - 12.2.8.2.7 Germany: Infectious Disease Diagnostics Market, by End User, 2020-2030 (US$ Million) 122
  - 12.2.8.3 France. 123
    - 12.2.8.3.1 Overview
    - 12.2.8.3.2 France Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 123
    - 12.2.8.3.3 France: Infectious Disease Diagnostics Market, by Product, 2020-2030 (US$ Million) 123
    - 12.2.8.3.4 France: Infectious Disease Diagnostics Market, by Technology, 2020-2030 (US$ Million) 125
    - 12.2.8.3.4.1 France: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million) 125
    - 12.2.8.3.4.2 France: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million) 126
    - 12.2.8.3.5 France: Infectious Disease Diagnostics Market, by Application Type, 2020-2030 (US$ Million) 126
    - 12.2.8.3.6 France: Infectious Disease Diagnostics Market, by Testing Type, 2020-2030 (US$ Million) 127
    - 12.2.8.3.6.1 France: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million) 127
    - 12.2.8.3.7 France: Infectious Disease Diagnostics Market, by End User, 2020-2030 (US$ Million) 128
  - 12.2.8.4 Italy. 129
    - 12.2.8.4.1 Overview
    - 12.2.8.4.2 Italy Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 129
    - 12.2.8.4.3 Italy: Infectious Disease Diagnostics Market, by Product, 2020-2030 (US$ Million) 129
    - 12.2.8.4.4 Italy: Infectious Disease Diagnostics Market, by Technology, 2020-2030 (US$ Million) 131
    - 12.2.8.4.4.1 Italy: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million) 131
    - 12.2.8.4.4.2 Italy: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million) 132
    - 12.2.8.4.5 Italy: Infectious Disease Diagnostics Market, by Application Type, 2020-2030 (US$ Million) 132
    - 12.2.8.4.6 Italy: Infectious Disease Diagnostics Market, by Testing Type, 2020-2030 (US$ Million) 132
    - 12.2.8.4.6.1 Italy: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million) 133
    - 12.2.8.4.7 Italy: Infectious Disease Diagnostics Market, by End User, 2020-2030 (US$ Million) 133
  - 12.2.8.5 Spain. 134
    - 12.2.8.5.1 Overview
    - 12.2.8.5.2 Spain Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 134
    - 12.2.8.5.3 Spain: Infectious Disease Diagnostics Market, by Product, 2020-2030 (US$ Million) 134
    - 12.2.8.5.4 Spain: Infectious Disease Diagnostics Market, by Technology, 2020-2030 (US$ Million) 136
    - 12.2.8.5.4.1 Spain: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million) 136
    - 12.2.8.5.4.2 Spain: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million) 137
    - 12.2.8.5.5 Spain: Infectious Disease Diagnostics Market, by Application Type, 2020-2030 (US$ Million) 137
    - 12.2.8.5.6 Spain: Infectious Disease Diagnostics Market, by Testing Type, 2020-2030 (US$ Million) 137
    - 12.2.8.5.6.1 Spain: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million) 138
    - 12.2.8.5.7 Spain: Infectious Disease Diagnostics Market, by End User, 2020-2030 (US$ Million) 138
  - 12.2.8.6 Rest of Europe. 139
    - 12.2.8.6.1 Overview
    - 12.2.8.6.2 Rest of Europe Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 139
    - 12.2.8.6.3 Rest of Europe: Infectious Disease Diagnostics Market, by Product, 2020-2030 (US$ Million) 139
    - 12.2.8.6.4 Rest of Europe: Infectious Disease Diagnostics Market, by Technology, 2020-2030 (US$ Million) 141
    - 12.2.8.6.4.1 Rest of Europe: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million) 141
    - 12.2.8.6.4.2 Rest of Europe: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million) 142
    - 12.2.8.6.5 Rest of Europe: Infectious Disease Diagnostics Market, by Application Type, 2020-2030 (US$ Million) 142
    - 12.2.8.6.6 Rest of Europe: Infectious Disease Diagnostics Market, by Testing Type, 2020-2030 (US$ Million) 143
    - 12.2.8.6.6.1 Rest of Europe: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million) 143
    - 12.2.8.6.7 Rest of Europe: Infectious Disease Diagnostics Market, by End User, 2020-2030 (US$ Million) 144
12.3 Asia Pacific Infectious Disease Diagnostics Market, Revenue and Forecast to 2030. 145
- 12.3.1 Overview. 145
- 12.3.2 Asia Pacific Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 146
- 12.3.3 Asia Pacific: Infectious Disease Diagnostics Market, by Product, 2020-2030 (US$ Million) 146
- 12.3.4 Asia Pacific: Infectious Disease Diagnostics Market, by Technology, 2020-2030 (US$ Million) 147
  - 12.3.4.1 Asia Pacific: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million) 147
  - 12.3.4.2 Asia Pacific: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million) 148
- 12.3.5 Asia Pacific: Infectious Disease Diagnostics Market, by Application Type, 2020-2030 (US$ Million) 148
- 12.3.6 Asia Pacific: Infectious Disease Diagnostics Market, by Testing Type, 2020-2030 (US$ Million) 149
  - 12.3.6.1 Asia Pacific: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million) 149
- 12.3.7 Asia Pacific: Infectious Disease Diagnostics Market, by End User, 2020-2030 (US$ Million) 150
- 12.3.8 Asia Pacific Infectious Disease Diagnostics Market, by Country. 151
  - 12.3.8.1 China. 151
    - 12.3.8.1.1 Overview
    - 12.3.8.1.2 China Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 151
    - 12.3.8.1.3 China: Infectious Disease Diagnostics Market, by Product, 2020-2030 (US$ Million) 153
    - 12.3.8.1.4 China: Infectious Disease Diagnostics Market, by Technology, 2020-2030 (US$ Million) 153
    - 12.3.8.1.4.1 China: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million) 154
    - 12.3.8.1.4.2 China: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million) 154
    - 12.3.8.1.5 China: Infectious Disease Diagnostics Market, by Application Type, 2020-2030 (US$ Million) 155
    - 12.3.8.1.6 China: Infectious Disease Diagnostics Market, by Testing Type, 2020-2030 (US$ Million) 155
    - 12.3.8.1.6.1 China: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million) 156
    - 12.3.8.1.7 China: Infectious Disease Diagnostics Market, by End User, 2020-2030 (US$ Million) 156
  - 12.3.8.2 Japan. 157
    - 12.3.8.2.1 Overview
    - 12.3.8.2.2 Japan Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 157
    - 12.3.8.2.3 Japan: Infectious Disease Diagnostics Market, by Product, 2020-2030 (US$ Million) 157
    - 12.3.8.2.4 Japan: Infectious Disease Diagnostics Market, by Technology, 2020-2030 (US$ Million) 159
    - 12.3.8.2.4.1 Japan: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million) 159
    - 12.3.8.2.4.2 Japan: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million) 160
    - 12.3.8.2.5 Japan: Infectious Disease Diagnostics Market, by Application Type, 2020-2030 (US$ Million) 160
    - 12.3.8.2.6 Japan: Infectious Disease Diagnostics Market, by Testing Type, 2020-2030 (US$ Million) 160
    - 12.3.8.2.6.1 Japan: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million) 161
    - 12.3.8.2.7 Japan: Infectious Disease Diagnostics Market, by End User, 2020-2030 (US$ Million) 161
  - 12.3.8.3 India. 162
    - 12.3.8.3.1 Overview
    - 12.3.8.3.2 India Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 162
    - 12.3.8.3.3 India: Infectious Disease Diagnostics Market, by Product, 2020-2030 (US$ Million) 162
    - 12.3.8.3.4 India: Infectious Disease Diagnostics Market, by Technology, 2020-2030 (US$ Million) 164
    - 12.3.8.3.4.1 India: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million) 164
    - 12.3.8.3.4.2 India: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million) 165
    - 12.3.8.3.5 India: Infectious Disease Diagnostics Market, by Application Type, 2020-2030 (US$ Million) 165
    - 12.3.8.3.6 India: Infectious Disease Diagnostics Market, by Testing Type, 2020-2030 (US$ Million) 165
    - 12.3.8.3.6.1 India: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million) 166
    - 12.3.8.3.7 India: Infectious Disease Diagnostics Market, by End User, 2020-2030 (US$ Million) 166
  - 12.3.8.4 South Korea. 167
    - 12.3.8.4.1 Overview
    - 12.3.8.4.2 South Korea Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 167
    - 12.3.8.4.3 South Korea: Infectious Disease Diagnostics Market, by Product, 2020-2030 (US$ Million) 167
    - 12.3.8.4.4 South Korea: Infectious Disease Diagnostics Market, by Technology, 2020-2030 (US$ Million) 169
    - 12.3.8.4.4.1 South Korea: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million) 169
    - 12.3.8.4.4.2 South Korea: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million) 170
    - 12.3.8.4.5 South Korea: Infectious Disease Diagnostics Market, by Application Type, 2020-2030 (US$ Million) 170
    - 12.3.8.4.6 South Korea: Infectious Disease Diagnostics Market, by Testing Type, 2020-2030 (US$ Million) 170
    - 12.3.8.4.6.1 South Korea: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million) 171
    - 12.3.8.4.7 South Korea: Infectious Disease Diagnostics Market, by End User, 2020-2030 (US$ Million) 171
  - 12.3.8.5 Australia. 172
    - 12.3.8.5.1 Overview
    - 12.3.8.5.2 Australia Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 172
    - 12.3.8.5.3 Australia: Infectious Disease Diagnostics Market, by Product, 2020-2030 (US$ Million) 172
    - 12.3.8.5.4 Australia: Infectious Disease Diagnostics Market, by Technology, 2020-2030 (US$ Million) 174
    - 12.3.8.5.4.1 Australia: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million) 174
    - 12.3.8.5.4.2 Australia: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million) 175
    - 12.3.8.5.5 Australia: Infectious Disease Diagnostics Market, by Application Type, 2020-2030 (US$ Million) 175
    - 12.3.8.5.6 Australia: Infectious Disease Diagnostics Market, by Testing Type, 2020-2030 (US$ Million) 175
    - 12.3.8.5.6.1 Australia: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million) 176
    - 12.3.8.5.7 Australia: Infectious Disease Diagnostics Market, by End User, 2020-2030 (US$ Million) 176
  - 12.3.8.6 Rest of Asia Pacific. 177
    - 12.3.8.6.1 Overview
    - 12.3.8.6.2 Rest of Asia Pacific Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 177
    - 12.3.8.6.3 Rest of Asia Pacific: Infectious Disease Diagnostics Market, by Product, 2020-2030 (US$ Million) 177
    - 12.3.8.6.4 Rest of Asia Pacific: Infectious Disease Diagnostics Market, by Technology, 2020-2030 (US$ Million) 179
    - 12.3.8.6.4.1 Rest of Asia Pacific: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million) 179
    - 12.3.8.6.4.2 Rest of Asia Pacific: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million) 180
    - 12.3.8.6.5 Rest of Asia Pacific: Infectious Disease Diagnostics Market, by Application Type, 2020-2030 (US$ Million) 180
    - 12.3.8.6.6 Rest of Asia Pacific: Infectious Disease Diagnostics Market, by Testing Type, 2020-2030 (US$ Million) 181
    - 12.3.8.6.6.1 Rest of Asia Pacific: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million) 181
    - 12.3.8.6.7 Rest of Asia Pacific: Infectious Disease Diagnostics Market, by End User, 2020-2030 (US$ Million) 182
12.4 Middle East & Africa Infectious Disease Diagnostics Market, Revenue and Forecast to 2030. 183
- 12.4.1 Overview. 183
- 12.4.2 Middle East & Africa Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 184
- 12.4.3 Middle East & Africa: Infectious Disease Diagnostics Market, by Product, 2020-2030 (US$ Million) 184
- 12.4.4 Middle East & Africa: Infectious Disease Diagnostics Market, by Technology, 2020-2030 (US$ Million) 185
  - 12.4.4.1 Middle East & Africa: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million) 185
  - 12.4.4.2 Middle East & Africa: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million) 186
- 12.4.5 Middle East & Africa: Infectious Disease Diagnostics Market, by Application Type, 2020-2030 (US$ Million) 186
- 12.4.6 Middle East & Africa: Infectious Disease Diagnostics Market, by Testing Type, 2020-2030 (US$ Million) 187
  - 12.4.6.1 Middle East & Africa: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million) 187
- 12.4.7 Middle East & Africa: Infectious Disease Diagnostics Market, by End User, 2020-2030 (US$ Million) 188
  - 12.4.7.1 Middle East & Africa Infectious Disease Diagnostics Market, by Country. 188
  - 12.4.7.2 Saudi Arabia. 189
    - 12.4.7.2.1 Overview
    - 12.4.7.2.2 Saudi Arabia Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 189
    - 12.4.7.2.3 Saudi Arabia: Infectious Disease Diagnostics Market, by Product, 2020-2030 (US$ Million) 189
    - 12.4.7.2.4 Saudi Arabia: Infectious Disease Diagnostics Market, by Technology, 2020-2030 (US$ Million) 191
    - 12.4.7.2.4.1 Saudi Arabia: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million) 191
    - 12.4.7.2.4.2 Saudi Arabia: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million) 192
    - 12.4.7.2.5 Saudi Arabia: Infectious Disease Diagnostics Market, by Application Type, 2020-2030 (US$ Million) 192
    - 12.4.7.2.6 Saudi Arabia: Infectious Disease Diagnostics Market, by Testing Type, 2020-2030 (US$ Million) 192
    - 12.4.7.2.6.1 Saudi Arabia: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million) 193
    - 12.4.7.2.7 Saudi Arabia: Infectious Disease Diagnostics Market, by End User, 2020-2030 (US$ Million) 193
  - 12.4.7.3 South Africa. 194
    - 12.4.7.3.1 Overview
    - 12.4.7.3.2 South Africa Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 194
    - 12.4.7.3.3 South Africa: Infectious Disease Diagnostics Market, by Product, 2020-2030 (US$ Million) 194
    - 12.4.7.3.4 South Africa: Infectious Disease Diagnostics Market, by Technology, 2020-2030 (US$ Million) 196
    - 12.4.7.3.4.1 South Africa: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million) 196
    - 12.4.7.3.4.2 South Africa: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million) 197
    - 12.4.7.3.5 South Africa: Infectious Disease Diagnostics Market, by Application Type, 2020-2030 (US$ Million) 197
    - 12.4.7.3.6 South Africa: Infectious Disease Diagnostics Market, by Testing Type, 2020-2030 (US$ Million) 197
    - 12.4.7.3.6.1 South Africa: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million) 198
    - 12.4.7.3.7 South Africa: Infectious Disease Diagnostics Market, by End User, 2020-2030 (US$ Million) 198
  - 12.4.7.4 UAE. 199
    - 12.4.7.4.1 Overview
    - 12.4.7.4.2 UAE Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 199
    - 12.4.7.4.3 UAE: Infectious Disease Diagnostics Market, by Product, 2020-2030 (US$ Million) 199
    - 12.4.7.4.4 UAE: Infectious Disease Diagnostics Market, by Technology, 2020-2030 (US$ Million) 201
    - 12.4.7.4.4.1 UAE: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million) 201
    - 12.4.7.4.4.2 UAE: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million) 202
    - 12.4.7.4.5 UAE: Infectious Disease Diagnostics Market, by Application Type, 2020-2030 (US$ Million) 202
    - 12.4.7.4.6 UAE: Infectious Disease Diagnostics Market, by Testing Type, 2020-2030 (US$ Million) 202
    - 12.4.7.4.6.1 UAE: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million) 203
    - 12.4.7.4.7 UAE: Infectious Disease Diagnostics Market, by End User, 2020-2030 (US$ Million) 203
  - 12.4.7.5 Rest of Middle East & Africa. 204
    - 12.4.7.5.1 Overview
    - 12.4.7.5.2 Rest of Middle East & Africa Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 204
    - 12.4.7.5.3 Rest of Middle East & Africa: Infectious Disease Diagnostics Market, by Product, 2020-2030 (US$ Million) 204
    - 12.4.7.5.4 Rest of Middle East & Africa: Infectious Disease Diagnostics Market, by Technology, 2020-2030 (US$ Million) 206
    - 12.4.7.5.4.1 Rest of Middle East & Africa: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million) 206
    - 12.4.7.5.4.2 Rest of Middle East & Africa: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million) 207
    - 12.4.7.5.5 Rest of Middle East & Africa: Infectious Disease Diagnostics Market, by Application Type, 2020-2030 (US$ Million) 207
    - 12.4.7.5.6 Rest of Middle East & Africa: Infectious Disease Diagnostics Market, by Testing Type, 2020-2030 (US$ Million) 208
    - 12.4.7.5.6.1 Rest of Middle East & Africa: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million) 208
    - 12.4.7.5.7 Rest of Middle East & Africa: Infectious Disease Diagnostics Market, by End User, 2020-2030 (US$ Million) 209
12.5 South & Central America Infectious Disease Diagnostics Market, Revenue and Forecast to 2030. 210
- 12.5.1 Overview. 210
- 12.5.2 South & Central America Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 211
- 12.5.3 South & Central America: Infectious Disease Diagnostics Market, by Product, 2020-2030 (US$ Million) 211
- 12.5.4 South & Central America: Infectious Disease Diagnostics Market, by Technology, 2020-2030 (US$ Million) 212
  - 12.5.4.1 South & Central America: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million) 212
  - 12.5.4.2 South & Central America: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million) 213
- 12.5.5 South & Central America: Infectious Disease Diagnostics Market, by Application Type, 2020-2030 (US$ Million) 213
- 12.5.6 South & Central America: Infectious Disease Diagnostics Market, by Testing Type, 2020-2030 (US$ Million) 214
  - 12.5.6.1 South & Central America: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million) 214
- 12.5.7 South & Central America: Infectious Disease Diagnostics Market, by End User, 2020-2030 (US$ Million) 215
- 12.5.8 South & Central America Infectious Disease Diagnostics Market, by Country. 215
  - 12.5.8.1 Brazil 216
    - 12.5.8.1.1 Overview
    - 12.5.8.1.2 Brazil Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 216
    - 12.5.8.1.3 Brazil: Infectious Disease Diagnostics Market, by Product, 2020-2030 (US$ Million) 216
    - 12.5.8.1.4 Brazil: Infectious Disease Diagnostics Market, by Technology, 2020-2030 (US$ Million) 218
    - 12.5.8.1.4.1 Brazil: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million) 218
    - 12.5.8.1.4.2 Brazil: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million) 219
    - 12.5.8.1.5 Brazil: Infectious Disease Diagnostics Market, by Application Type, 2020-2030 (US$ Million) 219
    - 12.5.8.1.6 Brazil: Infectious Disease Diagnostics Market, by Testing Type, 2020-2030 (US$ Million) 219
    - 12.5.8.1.6.1 Brazil: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million) 220
    - 12.5.8.1.7 Brazil: Infectious Disease Diagnostics Market, by End Use

02-2025-2992
(주말 및 공휴일 제외)

라이선스 / 가격

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다.

US $ 4,450

￦ 6,314,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,450

￦ 9,153,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,450

￦ 11,991,000

※ 부가세 별도